EMEA-000081-PIP01-07-M11

Key facts

Invented name
Pradaxa
Active substance
Dabigatran etexilate mesilate
Therapeutic area
  • Cardiovascular diseases
  • Haematology-Hemostaseology
Decision number
P/0399/2018
PIP number
EMEA-000081-PIP01-07-M11
Pharmaceutical form(s)
  • Capsule, hard
  • Age-appropriate formulation
Condition(s) / indication(s)
  • Prevention of thromboembolic events
  • Treatment of thromboembolic events
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271
E-mail: paediatrics@boehringer-ingelheim.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating